[Combined administration of human chorionic gonadotropin and human menopausal gonadotropin in idiopathic male infertility].
Clinical experiences of HCG-HMG therapy for 56 cases of idiopathic male infertility were studied. Serum levels of LH, FSH and testosterone were measured before therapy. Sperm density improved in 25% of all cases. In the low FSH group, sperm density showed a high rate of improvement. The basal FSH was the best indicator to predict the prognosis of fertility. Additional measurements of LH and FSH response to GnRH gave further information on the prospect of fertility.
D006063:Chorionic Gonadotropin / Q000008:administration & dosage* / Q000494:pharmacology; D004359:Drug Therapy, Combination; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006801:Humans; D007248:Infertility, Male / Q000097:blood / Q000188:drug therapy*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008596:Menotropins / Q000008:administration & dosage* / Q000494:pharmacology; D013076:Sperm Count / Q000187:drug effects; D013739:Testosterone / Q000097:blood
D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D008596:Menotropins; D007986:Luteinizing Hormone